Joseph J. Eron Jr., M.D.
He graduated from Harvard Medical School, completed his residency in Internal Medicine and Infectious Diseases Fellowship at the Massachusetts General Hospital. He has been involved in clinical and translational HIV research and HIV and Infectious Diseases clinic care at UNC-Chapel Hill for 14 years.
He is the principal investigator of the UNC AIDS Clinical Research Group, which includes the activities of the AIDS Clinical Trials Unit of the NIAID-funded multi-center ACTG and other HIV/AIDS clinical research activities including investigator-initiated clinical research and industry-sponsored clinical research studies. This research includes international clinical trials research with the ACTG and the HPTN and support of R01, CIPRA and CDC-based research in Malawi.
He is the director for the Clinical Core of the UNC Center for AIDS Research. This Core is responsible for support of NIH-sponsored or investigator-initiated HIV/AIDS translational research.
Dr. Eron and his research group, in collaboration with SAS, have also created a CFAR-supported Clinical and Research Database drawing on 1,500 HIV-infected clinic patients from urban and rural eastern North Carolina and relying on electronic data transfer and comprehensive chart reviews. This group is also assisting investigators who are establishing a similar database in Lilongwe, Malawi. His research group includes three physician clinical scientists, one post graduate M.D. fellow, an epidemiologist, three epidemiology Ph.D. candidates, one computer programmer, nine R.N./N.P. or P.A. research coordinators, six research assistants and appropriate support staff.
He is also the associate director of the UNC General Clinical Research Center (GCRC). He has been involved in the planning of multiple teaching conferences and symposia on a local and national level and has presented at national and international meetings.
He has actively participated in the training of international investigators in the conduct of HIV clinical research trials with investigators from Malawi, South Africa, Cameroon and China.
Dr. Eron has received research support from Merck & Co., Panacos and GlaxoSmithKline. He serves as a consultant for Merck & Co., Avexa, Panacos, Bristol-Myers Squibb, GlaxoSmithKline, Tibotec Therapeutics, Virco, Trimeris, Inc. and Pfizer, Inc. He also serves on speakers bureaus for Merck, Gilead, Tibotec, Bristol-Myers Squibb and Roche Laboratories.